Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,215 JPY | -0.19% | +6.31% | +17.67% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The stock, which is currently worth 2024 to 0.52 times its sales, is clearly overvalued in comparison with peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's earnings growth outlook lacks momentum and is a weakness.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- The company is highly valued given the cash flows generated by its activity.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+17.67% | 1.72B | C+ | ||
+3.59% | 102B | A- | ||
-7.19% | 60.79B | A- | ||
+74.76% | 48.86B | B | ||
+13.97% | 37.96B | B | ||
+4.56% | 32.37B | A- | ||
+14.72% | 20.64B | B- | ||
+11.17% | 16.58B | C+ | ||
+8.81% | 13.93B | B- | ||
-3.19% | 13.25B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4118 Stock
- Ratings Kaneka Corporation